Sepsis research
- 1 February 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (2) , 427-430
- https://doi.org/10.1097/00003246-199902000-00054
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Confirmatory interleukin-1 receptor antagonist trial in severe sepsisCritical Care Medicine, 1997
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- INTERSEPTCritical Care Medicine, 1996
- Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinNew England Journal of Medicine, 1996
- Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shockCritical Care Medicine, 1996
- CDP571, a humanized antibody to human tumor necrosis factor-alphaCritical Care Medicine, 1995
- Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis SyndromeJAMA, 1995
- Treatment of Septic Shock with Human Monoclonal Antibody HA-1AAnnals of Internal Medicine, 1994
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994
- Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsisCritical Care Medicine, 1993